These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 24699298)

  • 1. Monotherapy with amikacin or piperacillin-tazobactum empirically in neonates at risk for early-onset sepsis: a randomized controlled trial.
    Tewari VV; Jain N
    J Trop Pediatr; 2014 Aug; 60(4):297-302. PubMed ID: 24699298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial using piperacillin versus ampicillin and amikacin for treatment of premature neonates with risk factors for sepsis.
    Hammerberg O; Kurnitzki C; Watts J; Rosenbloom D
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):241-4. PubMed ID: 2496993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of piperacillin/tazobactam (in association with amikacin) in neonatal sepsis: efficacy and safety data.
    Flidel-Rimon O; Friedman S; Leibovitz E; Shinwell ES
    Scand J Infect Dis; 2006; 38(1):36-42. PubMed ID: 16338836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two empiric antibiotic regimen in late onset neonatal sepsis--a randomized controlled trial.
    Ramasamy S; Biswal N; Bethou A; Mathai B
    J Trop Pediatr; 2014 Feb; 60(1):83-6. PubMed ID: 24064510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of 7-Day vs. 14-Day antibiotics for neonatal sepsis.
    Chowdhary G; Dutta S; Narang A
    J Trop Pediatr; 2006 Dec; 52(6):427-32. PubMed ID: 17030532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
    Yildirim I; Aytac S; Ceyhan M; Cetin M; Tuncer M; Cengiz AB; Secmeer G; Yetgin S
    Pediatr Hematol Oncol; 2008 Jun; 25(4):291-9. PubMed ID: 18484473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS).
    Thomson KM; Dyer C; Liu F; Sands K; Portal E; Carvalho MJ; Barrell M; Boostrom I; Dunachie S; Farzana R; Ferreira A; Frayne F; Hassan B; Jones E; Jones L; Mathias J; Milton R; Rees J; Chan GJ; Bekele D; Mahlet A; Basu S; Nandy RK; Saha B; Iregbu K; Modibbo F; Uwaezuoke S; Zahra R; Shirazi H; Syed NU; Mazarati JB; Rucogoza A; Gaju L; Mehtar S; Bulabula ANH; Whitelaw A; van Hasselt JGC; Walsh TR;
    Lancet Infect Dis; 2021 Dec; 21(12):1677-1688. PubMed ID: 34384533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
    Oztoprak N; Piskin N; Aydemir H; Celebi G; Akduman D; Keskin AS; Gokmen A; Engin H; Ankarali H
    Jpn J Clin Oncol; 2010 Aug; 40(8):761-7. PubMed ID: 20427546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
    Janković B; Pasić S; Marković M; Veljković D; Milicić M
    Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
    Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and etiology of neonatal sepsis in Tikur Anbessa University Hospital, Ethiopia.
    Shitaye D; Asrat D; Woldeamanuel Y; Worku B
    Ethiop Med J; 2010 Jan; 48(1):11-21. PubMed ID: 20607993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is ceftizoxime an appropriate surrogate for amikacin in neonatal sepsis treatment? A randomized clinical trial.
    Taheri PA; Eslamieh H; Salamati P
    Acta Med Iran; 2011; 49(8):499-503. PubMed ID: 22009803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
    Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia.
    Del Favero A; Menichetti F; Martino P; Bucaneve G; Micozzi A; Gentile G; Furno P; Russo D; D'Antonio D; Ricci P; Martino B; Mandelli F;
    Clin Infect Dis; 2001 Oct; 33(8):1295-301. PubMed ID: 11565068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing trend of empirical antibiotic regimen: experience of two studies at different periods in a neonatal intensive care unit in Tehran, Iran.
    Marzban A; Samaee H; Mosavinasab N
    Acta Med Iran; 2010; 48(5):312-5. PubMed ID: 21287464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in antibiotic susceptibility and incidence of late-onset Klebsiella pneumoniae neonatal sepsis over a six-year period in a neonatal intensive care unit in Karachi, Pakistan.
    Saleem AF; Qamar FN; Shahzad H; Qadir M; Zaidi AK
    Int J Infect Dis; 2013 Nov; 17(11):e961-5. PubMed ID: 23759260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia.
    Zengin E; Sarper N; Kılıç SC
    Pediatr Hematol Oncol; 2011 May; 28(4):311-20. PubMed ID: 21524156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The etiology of neonatal sepsis and patterns of antibiotic resistance.
    Waheed M; Laeeq A; Maqbool S
    J Coll Physicians Surg Pak; 2003 Aug; 13(8):449-52. PubMed ID: 12921682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro activities of ceftazidime, piperacillin-tazobactam, and cefoperazone-sulbactam, and the implication on empirical therapy in patients with cancer.
    Prabhash K; Medhekar A; Biswas S; Kurkure P; Nair R; Kelkar R
    Indian J Cancer; 2009; 46(4):318-22. PubMed ID: 19749462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.